You can donate money to support the Her2 Breast cancer foundation. You can even participate in the marathons they have and or you can supply Breast cancer patients with supplies.
This website offers its user access to information, stories, and message boards containing the accounts of other women with the same cancer. HER2/neu refers to a specific mutation that is found in certain breast cancers.
"HER2 breast cancer is named for the gene that helps cells grow, divide and repair. If a woman has cancer in this gene it grows faster and has a greater chance of returning. Treatments available for this type of cancer include chemotherapy, radiation therapy and a lumpectomy or mastectomy."
Her2 is more aggressive than other breast cancers because hormone treatment is less effective than if you used the treatment on other types of breast cancers.
Negative for estrogen receptors (ER-), progesterone receptors (PR-), and HER2 (HER2-). Testing negative for all three means the cancer cell is triple-negative.
Elizabeth Edwards had breast cancer that had spread to other parts of her body.
HER2, or human epidermal growth factor receptor 2, is a protein that promotes the growth of cancer cells. In some cancers, notably breast cancer, the cancer cells have too much HER2 protein or too many copies of the HER2 gene, leading to more aggressive tumor growth. This type of cancer is referred to as HER2-positive.
HER2 (Human Epidermal growth factor Receptor 2) is a protein that is overexpressed in some types of cancer, particularly breast cancer. It plays a role in cell growth and division by signaling pathways that regulate cellular functions. In certain cancers, high levels of HER2 can lead to aggressive tumor growth, making it a key target for specific therapies, such as trastuzumab (Herceptin). Testing for HER2 status is crucial for determining the appropriate treatment plan for patients.
How many type of breast cancer are there
Sophie I. Williams has written: 'HER2 and cancer' -- subject(s): HER-2 gene, Receptor, erbB-2, Breast, Cancer, Drug Delivery Systems, HER-2 protein, Genetic aspects
I believe if means ER-, PR-, and Her2+ Estrogen Receptor, Progesterone Receptor, and the orphan receptor Her2/Neu. So it means that both of the hormone receptors (ER and PR) are not expressed by the tumor, but that other known markers, like Her2 are expressed. Expressing (being positive) is a good thing because it gives the clinicians something to target.
I believe if means ER-, PR-, and Her2+ Estrogen Receptor, Progesterone Receptor, and the orphan receptor Her2/Neu. So it means that both of the hormone receptors (ER and PR) are not expressed by the tumor, but that other known markers, like Her2 are expressed. Expressing (being positive) is a good thing because it gives the clinicians something to target.
After cancer is gone, continuing treatment with Herceptin (trastuzumab) may help prevent recurrence in patients with HER2-positive breast cancer. Herceptin targets the HER2 protein, which can promote the growth of cancer cells, and ongoing treatment can help eliminate any remaining cancer cells that may not be detectable. However, the decision to continue Herceptin after cancer is in remission should be made in consultation with a healthcare provider, considering potential benefits and side effects. Regular monitoring is essential to assess the patient's response and adjust treatment as necessary.